Comparison of lixisenatide with sitagliptin and pioglitazone in non-alcoholic fatty liver diseases patients with type 2 diabetes after an acute coronary syndrome
Latest Information Update: 20 Jul 2017
At a glance
- Drugs Lixisenatide (Primary) ; Metformin; Pioglitazone; Sitagliptin
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 13 Jun 2017 Results presented at the 77th Annual Scientific Sessions of the American Diabetes Association
- 18 Oct 2016 New trial record
- 16 Sep 2016 Results presented at the 52nd Annual Meeting of the European Association for the Study of Diabetes